Revolution Medicines, Inc. (RVMD) Misses Q2 EPS by 19c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q2 EPS of ($1.31), $0.19 worse than the analyst estimate of ($1.12).

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
• Kotak Upgrades Narayana Hrudayalaya Ltd (NARH:IN) to Buy (1)
• Emkay Global Starts Urban Company (URBANCO:IN) at Buy (1)